Inventor

Tao Xin

Inventor
Toronto, CA

Overview

27→
Patents
1999–2018
Patent span
Human necessities
Primary field (CPC A)

Patents· 27 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds44%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
A61KPreparations for medical, dental or toiletry purposes18%
C07CAcyclic or carbocyclic compounds2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
PatentTitleYear
9,938,240Fluorinated derivatives of 3-hydroxypyridin-4-ones20189,550,733'Fluorinated derivatives of 3-hydroxypyridin-4-ones'20179,073,865'Fluorinated derivates of 3-hydroxypyridin-4-ones'20158,148,394'Azaindoles having serotonin receptor affinity'20127,960,422'Pharmaceutically active compounds containing tetrazolyl and triazolyl rings'20117,902,401'Fluorinated compounds'20117,772,235'mGluR5 modulators'20107,691,892'Tetrazole compounds and their use as metabotropic glutamate receptor antagonists'20107,678,796'MGluR5 modulators I'20107,576,077'Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists'20097,476,684'Compounds for the treatment of neurological, psychiatric or pain disorders'20097,456,200'Compounds'20087,268,127'Azaindoles having serotonin receptor affinity'20077,112,595'Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists'20067,074,809'Compounds'20066,916,818'Azaindoles having serotonin receptor affinity'20056,897,215'Compounds having 5-HT6 receptor antagonist activity'20056,716,837'Heterocyclic compounds for the treatment of migraine'20046,686,374'Azaindoles having serotonin receptor affinity'20046,635,639'Use of N-alkylamino-heterocylic compounds for the treatment of migraine'20036,562,809'3-bicycloindole compounds'20036,380,242'N-alkylamino-indoles for the treatment of migraine'20026,251,893'Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinity'20016,191,141'Azaindoles having serotonin receptor affinity'20016,133,287'Piperidine-indole compounds having 5-HT.sub.6 affinity'20006,100,291'Pyrrolidine-indole compounds having 5-HT.sub.6 affinity'20005,914,401'Methods for the manufacture of quinolone carboxylic acids derivatives and intermediates thereof'1999

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1999–2018Patents assigned to APOTEX INC (2)· patent assignee history
1999–2003Based in North York, CA· patent location history
2000Patents assigned to ALLELIX BIOPHARMA (2)· patent assignee history
2001–2007Patents assigned to NPS ALLELIX CORP (9)· patent assignee history
2001–2012Based in Toronto, CA· patent location history
2004–2018Based in Woodbridge, CA· patent location history
2005–2011Based in Ontario, CA· patent location history
2006–2011Patents assigned to ASTRAZENECA AB (9)· patent assignee history
2006–2012Patents assigned to NPS PHARMA INC (3)· patent assignee history
2009–2010Based in Mississauga, CA· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ASTRAZENECA AB92006–2011
NPS ALLELIX CORP92001–2007
NPS PHARMA INC32006–2012
ALLELIX BIOPHARMA22000
APOTEX INC21999–2018
Locations
LocationPatentsSpan
Toronto, CA122001–2012
Woodbridge, CA62004–2018
North York, CA51999–2003
Ontario, CA22005–2011
Mississauga, CA22009–2010